Hess KR - Search Results

1

Phase 2 study of pembrolizumab in patients with advanced rare cancers.

Naing A, Meric-Bernstam F, Stephen B, Karp DD, Hajjar J, Rodon Ahnert J, Piha-Paul SA, Colen RR, Jimenez C, Raghav KP, Ferrarotto R, Tu SM, Campbell M, Wang L, Sabir SH, Tapia C, Bernatchez C, Frumovitz M, Tannir N, Ravi V, Khan S, Painter JM, Abonofal A, Gong J, Alshawa A, McQuinn LM, Xu M, Ahmed S, Subbiah V, Hong DS, Pant S, Yap TA, Tsimberidou AM, Dumbrava EEI, Janku F, Fu S, Simon RM, Hess KR, Varadhachary GR, Habra MA. Naing A, et al. Among authors: hess kr. J Immunother Cancer. 2020 Mar;8(1):e000347. doi: 10.1136/jitc-2019-000347. J Immunother Cancer. 2020. PMID: 32188704 Free PMC article. Clinical Trial.

2

Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer.

Vassilopoulou-Sellin R, Guinee VF, Klein MJ, Taylor SH, Hess KR, Schultz PN, Samaan NA. Vassilopoulou-Sellin R, et al. Among authors: hess kr. Cancer. 1993 May 15;71(10):3119-23. doi: 10.1002/1097-0142(19930515)71:10<3119::aid-cncr2820711037>3.0.co;2-8. Cancer. 1993. PMID: 8490842

3

Phase I bioequivalency study of MitoExtra and mitomycin C in patients with solid tumors.

Kozuch P, Hoff PM, Hess K, Adams J, Newman RA, Lee F, Pazdur R. Kozuch P, et al. Cancer. 2001 Feb 15;91(4):815-21. Cancer. 2001. PMID: 11241251 Clinical Trial.

4

Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas.

Meric F, Hess KR, Varma DG, Hunt KK, Pisters PW, Milas KM, Patel SR, Benjamin RS, Plager C, Papadopoulos NE, Burgess MA, Pollock RE, Feig BW. Meric F, et al. Among authors: hess kr. Cancer. 2002 Sep 1;95(5):1120-6. doi: 10.1002/cncr.10794. Cancer. 2002. PMID: 12209699 Free article.

5

CI-980 for the treatment of recurrent or progressive malignant gliomas: national central nervous system consortium phase I-II evaluation of CI-980.

Kunschner LJ, Fine H, Hess K, Jaeckle K, Kyritsis AP, Yung WK. Kunschner LJ, et al. Cancer Invest. 2002;20(7-8):948-54. doi: 10.1081/cnv-120005910. Cancer Invest. 2002. PMID: 12449727 Clinical Trial.

6

Metastatic patterns in adenocarcinoma.

Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, Abbruzzese JL. Hess KR, et al. Cancer. 2006 Apr 1;106(7):1624-33. doi: 10.1002/cncr.21778. Cancer. 2006. PMID: 16518827 Free article.

7

Outcome of gastric cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survival.

Rohatgi PR, Yao JC, Hess K, Schnirer I, Rashid A, Mansfield PF, Pisters PW, Ajani JA. Rohatgi PR, et al. Cancer. 2006 Dec 1;107(11):2576-80. doi: 10.1002/cncr.22317. Cancer. 2006. PMID: 17075877 Free article.

8

Clinical and in vitro studies of imatinib in advanced carcinoid tumors.

Yao JC, Zhang JX, Rashid A, Yeung SC, Szklaruk J, Hess K, Xie K, Ellis L, Abbruzzese JL, Ajani JA. Yao JC, et al. Clin Cancer Res. 2007 Jan 1;13(1):234-40. doi: 10.1158/1078-0432.CCR-06-1618. Clin Cancer Res. 2007. PMID: 17200360 Clinical Trial.

9

Impact of phase II trials with progression-free survival as end-points on survival-based phase III studies in patients with anaplastic gliomas.

Levin VA, Ictech S, Hess KR. Levin VA, et al. Among authors: hess kr. BMC Cancer. 2007 Jun 22;7:106. doi: 10.1186/1471-2407-7-106. BMC Cancer. 2007. PMID: 17587447 Free PMC article. Clinical Trial.

10

Effect of timing of metastasis/disease recurrence and histologic differentiation on survival of patients with advanced gastric cancer.

Patel PR, Yao JC, Hess K, Schnirer I, Rashid A, Ajani JA. Patel PR, et al. Cancer. 2007 Nov 15;110(10):2186-90. doi: 10.1002/cncr.23046. Cancer. 2007. PMID: 17896785 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

419 results

Search Page

Filters